Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline

S Melmed, FF Casanueva, AR Hoffman… - The Journal of …, 2011 - academic.oup.com
abstract Objective: The aim was to formulate practice guidelines for the diagnosis and
treatment of hyperprolactinemia. Participants: The Task Force consisted of Endocrine …

Advances in the treatment of prolactinomas

MP Gillam, ME Molitch, G Lombardi… - Endocrine …, 2006 - academic.oup.com
Prolactinomas account for approximately 40% of all pituitary adenomas and are an
important cause of hypogonadism and infertility. The ultimate goal of therapy for …

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

FF Casanueva, ME Molitch, JA Schlechte… - Clinical …, 2006 - Wiley Online Library
In June 2005, an ad hoc Expert Committee formed by the Pituitary Society convened during
the 9th International Pituitary Congress in San Diego, California. Members of this committee …

Diagnosis and management of hyperprolactinemia

O Serri, CL Chik, E Ur, S Ezzat - Cmaj, 2003 - Can Med Assoc
PROLACTIN IS A PITUITARY HORMONE that plays a pivotal role in a variety of reproductive
functions. Hyperprolactinemia is a common condition that can result from a number of …

Hyperprolactinemia and prolactinomas

T Mancini, FF Casanueva, A Giustina - Endocrinology and metabolism …, 2008 - Elsevier
Hyperprolactinemia is one of the most frequently diagnosed clinical disorders in routine
endocrine practice. Any process interfering with dopamine synthesis, its transport to the …

Prolactinomas

A Klibanski - New England Journal of Medicine, 2010 - Mass Medical Soc
A 42-year-old man presents with decreased libido, erectile dysfunction, and headaches. He
reports no weight change, gynecomastia, fatigue, or other symptoms. He takes no …

Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study

E Delgrange, J Trouillas, D Maiter… - The Journal of …, 1997 - academic.oup.com
Prolactinomas in women commonly present as small intrasellar tumors, but are usually
much larger in men. This discrepancy has generally been attributed to differences in the …

[HTML][HTML] Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia

A Colao, A Di Sarno, P Cappabianca… - … England Journal of …, 2003 - Mass Medical Soc
Background Whether the withdrawal of treatment in patients with nontumoral
hyperprolactinemia, microprolactinomas, or macroprolactinomas is safe and effective has …

Prolactinoma

JA Schlechte - New England Journal of Medicine, 2003 - Mass Medical Soc
A 22-year-old woman who wants to become pregnant has had no menses since she
discontinued the use of an oral contraceptive one year ago, and recently, galactorrhea …

Pituitary tumors: pathophysiology, clinical manifestations and management.

BM Arafah, MP Nasrallah - Endocrine-related cancer, 2001 - erc.bioscientifica.com
Pituitary tumors are frequently encountered intracranial neoplasms. They present with a
variety of clinical manifestations that include symptoms and signs of excessive hormone …